Viral interaction: A possible contributing factor in head and neck cancer progression

Michael Underbrink, Stephen L. Hoskins, Anna M. Pou, Thomas Albrecht

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Conclusion. Human herpesvirus-8 could potentiate the effects of human papillomavirus (HPV)-16 on cell cycle dysregulation by up-regulating the transcription of HPV-16 E7, which can lead to malignant transformation of normal epithelial cells. Objectives. High-risk HPV-16 is known for its association with development of head and neck carcinoma, leading to considerable morbidity and mortality worldwide. HPV-16 produces two early proteins, E6 and E7, that can disrupt the cell cycle and transform cells. Other viruses may potentiate dysregulation of the cell cycle by HPV-16. Herpes viruses are known to produce replication transcription activators, which may contribute to the malignant transformation of normal cells. This study aimed to determine if the ORF50/Rta protein of HHV-8 binds to genomic regions within HPV-16 and alters the transcription and/or translation of E6 and E7 in HPV-infected cells. Materials and methods. Protein shift assays determined the binding potential of ORF50 to various HPV-16 genomic regions. A real-time polymerase chain reaction (PCR) assay quantified the effect of ORF50 on the transcription of E6 and E7 within these cells. Finally, immunofluorescent confocal microscopy was used to quantify E6 and E7 protein levels within transfected cells and study their localization patterns. Results. The results reveal potential ORF50/Rta binding sites within HPV-16 and a significant up-regulation of E7 transcription in ORF50 transfected cells.

Original languageEnglish (US)
Pages (from-to)1361-1369
Number of pages9
JournalActa Oto-Laryngologica
Volume128
Issue number12
DOIs
StatePublished - 2008

Fingerprint

Human papillomavirus 16
Head and Neck Neoplasms
Cell Cycle
Viruses
Human Herpesvirus 8
Proteins
Confocal Microscopy
Real-Time Polymerase Chain Reaction
Neck
Up-Regulation
Epithelial Cells
Binding Sites
Head
Morbidity
Carcinoma
Mortality

Keywords

  • E6
  • E7
  • Head and neck cancer
  • HPV
  • Human herpesvirus 8
  • Human papillomavirus
  • ORF 50

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Viral interaction : A possible contributing factor in head and neck cancer progression. / Underbrink, Michael; Hoskins, Stephen L.; Pou, Anna M.; Albrecht, Thomas.

In: Acta Oto-Laryngologica, Vol. 128, No. 12, 2008, p. 1361-1369.

Research output: Contribution to journalArticle

Underbrink, Michael ; Hoskins, Stephen L. ; Pou, Anna M. ; Albrecht, Thomas. / Viral interaction : A possible contributing factor in head and neck cancer progression. In: Acta Oto-Laryngologica. 2008 ; Vol. 128, No. 12. pp. 1361-1369.
@article{c75cd8a01e4c4f4c9fbb18c1dac10c1c,
title = "Viral interaction: A possible contributing factor in head and neck cancer progression",
abstract = "Conclusion. Human herpesvirus-8 could potentiate the effects of human papillomavirus (HPV)-16 on cell cycle dysregulation by up-regulating the transcription of HPV-16 E7, which can lead to malignant transformation of normal epithelial cells. Objectives. High-risk HPV-16 is known for its association with development of head and neck carcinoma, leading to considerable morbidity and mortality worldwide. HPV-16 produces two early proteins, E6 and E7, that can disrupt the cell cycle and transform cells. Other viruses may potentiate dysregulation of the cell cycle by HPV-16. Herpes viruses are known to produce replication transcription activators, which may contribute to the malignant transformation of normal cells. This study aimed to determine if the ORF50/Rta protein of HHV-8 binds to genomic regions within HPV-16 and alters the transcription and/or translation of E6 and E7 in HPV-infected cells. Materials and methods. Protein shift assays determined the binding potential of ORF50 to various HPV-16 genomic regions. A real-time polymerase chain reaction (PCR) assay quantified the effect of ORF50 on the transcription of E6 and E7 within these cells. Finally, immunofluorescent confocal microscopy was used to quantify E6 and E7 protein levels within transfected cells and study their localization patterns. Results. The results reveal potential ORF50/Rta binding sites within HPV-16 and a significant up-regulation of E7 transcription in ORF50 transfected cells.",
keywords = "E6, E7, Head and neck cancer, HPV, Human herpesvirus 8, Human papillomavirus, ORF 50",
author = "Michael Underbrink and Hoskins, {Stephen L.} and Pou, {Anna M.} and Thomas Albrecht",
year = "2008",
doi = "10.1080/00016480801965001",
language = "English (US)",
volume = "128",
pages = "1361--1369",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Viral interaction

T2 - A possible contributing factor in head and neck cancer progression

AU - Underbrink, Michael

AU - Hoskins, Stephen L.

AU - Pou, Anna M.

AU - Albrecht, Thomas

PY - 2008

Y1 - 2008

N2 - Conclusion. Human herpesvirus-8 could potentiate the effects of human papillomavirus (HPV)-16 on cell cycle dysregulation by up-regulating the transcription of HPV-16 E7, which can lead to malignant transformation of normal epithelial cells. Objectives. High-risk HPV-16 is known for its association with development of head and neck carcinoma, leading to considerable morbidity and mortality worldwide. HPV-16 produces two early proteins, E6 and E7, that can disrupt the cell cycle and transform cells. Other viruses may potentiate dysregulation of the cell cycle by HPV-16. Herpes viruses are known to produce replication transcription activators, which may contribute to the malignant transformation of normal cells. This study aimed to determine if the ORF50/Rta protein of HHV-8 binds to genomic regions within HPV-16 and alters the transcription and/or translation of E6 and E7 in HPV-infected cells. Materials and methods. Protein shift assays determined the binding potential of ORF50 to various HPV-16 genomic regions. A real-time polymerase chain reaction (PCR) assay quantified the effect of ORF50 on the transcription of E6 and E7 within these cells. Finally, immunofluorescent confocal microscopy was used to quantify E6 and E7 protein levels within transfected cells and study their localization patterns. Results. The results reveal potential ORF50/Rta binding sites within HPV-16 and a significant up-regulation of E7 transcription in ORF50 transfected cells.

AB - Conclusion. Human herpesvirus-8 could potentiate the effects of human papillomavirus (HPV)-16 on cell cycle dysregulation by up-regulating the transcription of HPV-16 E7, which can lead to malignant transformation of normal epithelial cells. Objectives. High-risk HPV-16 is known for its association with development of head and neck carcinoma, leading to considerable morbidity and mortality worldwide. HPV-16 produces two early proteins, E6 and E7, that can disrupt the cell cycle and transform cells. Other viruses may potentiate dysregulation of the cell cycle by HPV-16. Herpes viruses are known to produce replication transcription activators, which may contribute to the malignant transformation of normal cells. This study aimed to determine if the ORF50/Rta protein of HHV-8 binds to genomic regions within HPV-16 and alters the transcription and/or translation of E6 and E7 in HPV-infected cells. Materials and methods. Protein shift assays determined the binding potential of ORF50 to various HPV-16 genomic regions. A real-time polymerase chain reaction (PCR) assay quantified the effect of ORF50 on the transcription of E6 and E7 within these cells. Finally, immunofluorescent confocal microscopy was used to quantify E6 and E7 protein levels within transfected cells and study their localization patterns. Results. The results reveal potential ORF50/Rta binding sites within HPV-16 and a significant up-regulation of E7 transcription in ORF50 transfected cells.

KW - E6

KW - E7

KW - Head and neck cancer

KW - HPV

KW - Human herpesvirus 8

KW - Human papillomavirus

KW - ORF 50

UR - http://www.scopus.com/inward/record.url?scp=57349110655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349110655&partnerID=8YFLogxK

U2 - 10.1080/00016480801965001

DO - 10.1080/00016480801965001

M3 - Article

C2 - 18607925

AN - SCOPUS:57349110655

VL - 128

SP - 1361

EP - 1369

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 12

ER -